![]() DJ Melon Live Resin Diamonds & Sauce (1g) – Named after a unique formulation that combines KISH and AFD live resins, resulting in a melon-y aroma, DJ Melon is 99.9% THCa Diamonds smothered in a sweet terp sauce that evokes light citrus notes with subtle hints of pine.These sativa gummies have a sweet citrus, tangerine flavour inspired by the character of the flower. Tangerine Dream Cured Resin Gummies (4 x 2.5mg) – Made with strain-specific cured resin from premium dried flower extracted using Aurora's state-of-the-art hydrocarbon process.Bred from Aurora Medical's Vespera and Equiposa cultivars, Moon Berry is a great choice for those looking for a full-flavoured experience with moderate THC and balanced CBD. Moon Berry (3.5g & 14g flower, 3 x 0.5g pre-rolls) – A premium strain with a balanced 1:1 ratio of THC to CBD, Moon Berry has a delightful aroma of berries, cream and lemon. ![]() Hang-dried, hand-finished and hand-bottled for an excellent final product. The result is a pungent, powerful and 100% original indica with notes of gas, lavender and spice, delivering 24-30% THC. ![]() Pink Diesel '71 (3.5g & 14g flower, 3 x 0.5g pre-rolls) – A premium strain crossbred from two of San Rafael '71's most popular cultivars, Pink Kush and Driftwood Diesel.All told, the price of Aurora common stock has fallen over 80% from its Class Period high, causing investors in the Company to suffer massive losses. These revelations have caused the price of Aurora securities to plummet. Finally, on January 6, 2020, media reports stated that the Company had listed its nine-hectare greenhouse in Exeter, Ontario, for sale for $17 million. On December 21, 2019, Aurora announced that the Company’s Chief Corporate Officer would be stepping down. Then, on November 29, 2019, Marijuana Business Daily reported that Aurora had violated regulations for the sale of cannabis to German pharmacies. In addition, the Company revealed that it was halting construction on two key production facilities, its Aurora Nordic 2 facility in Denmark and its Aurora Sun facility in Medicine Hat, Alberta. ![]() The market learned the truth through a series of disclosures beginning on November 14, 2019, when the Company announced disappointing first quarter of fiscal 2020 results, reporting a 25% sequential sales decline and a 33% sequential consumer cannabis revenue decline. As a result of concealing this information from the market, the Company’s securities traded at artificially inflated prices throughout the Class Period. The litigation alleges that Defendants made false and misleading statements and omissions about Aurora’s business, financial performance and prospects. Specifically, Plaintiffs allege that Defendants failed to disclose that they had materially overstated the demand and potential market for Aurora’s consumer cannabis products, that the Company had failed to comply with licensing requirements in the all-important German market, and that the Company was suffering from liquidity constraints and the over-extension of capital commitments, among other misstatements. (“Aurora” or the “Company”) securities between Januto Novem(“Class Period”).Īurora Cannabis Inc., headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that include Aurora, CanniMed, MedReleaf, and San Rafael '71. On October 23, 2018, the company began listing its stock on the New York Stock Exchange. This is a Consolidated securities class action litigation brought on behalf of investors who purchased or otherwise acquired Aurora Cannabis Inc.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |